August 15, 2008, Jacksonville, FL: ENCO Analytix announces the U.S. Food and Drug Administration (FDA) completed a comprehensive inspection at the company’s facility in Jacksonville, FL on July 29-30, 2008. The inspection was related to the company’s registration with the FDA as an Analytical Laboratory and focused primarily on compliance with current Good Manufacturing Practices (cGMPs).
This was the first FDA inspection of ENCO Analytix’ Jacksonville facility. Notably, upon completion of the inspection, no observations were presented to company management. The company’s management is pleased with the outcome of this event, and continues the trend of successful inspections by both governmental and accrediting agencies including the Korean FDA, the U.S. Drug Enforcement Agency (DEA) and the American Association for Laboratory Accreditation (A2LA).
The favorable outcome of this inspection reaffirms ENCO Analytix’ focus to be a leading contract analytical laboratory, and its dedication to quality throughout its operations.
About ENCO Analytix, Inc.
ENCO Analytix, Inc. provides contract analytical services primarily to the medical device and pharmaceutical industries. The company specializes in providing high quality, timely results, in conformance with current Good Manufacturing Practices (cGMP). In addition to its Jacksonville FL facility, ENCO offers stability services from its Cary, NC location. Additional information about the company can be found at http://analytix.encolabs.com.
